The companies announced Dr. Atul Gawande, a professor at Harvard and the author of several books on health care, will lead the new health venture starting July 9. But other questions remain unanswered.
The fintech wants to facilitate loans for elective surgeries, auto repairs and jewelry purchases, but regulatory uncertainty — at the state and federal levels — casts a cloud over its business model.
If the company they plan to establish comes together and works — still a big if — it could give JPMorgan an edge in competing with other banks, lead to innovative payments and other products and create unforeseen issues.
JPMorgan Chase and Amazon have demonstrated substantial power to digitize their industries, even influencing the strategy of others. But automating and streamlining health care will be a particularly tough task.
